The first FDA and CE registered comprehensive women’s health monitoring platform with 99% of accuracy in clinical trials. Mira tracks cycles, predicts ovulation, monitors fetal health, measures ovarian reserve and detects menopause at home, with expandability into chronic disease monitoring, using the hospital-leveled technology within a palm-sized device. The data automatically syncs to the Mira app. The AI learns personal health patterns. The telemedicine connects users with doctors.

Founders:  Bin Miao, Sylvia Kang, Zheng Yang